Leary Megan C, Saver Jeffrey L
Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Cerebrovasc Dis. 2003;16(3):280-5. doi: 10.1159/000071128.
Recent estimates of stroke incidence in the US range from 760,000 to 780,000 annually, however these estimates do not reflect the incidence of silent infarcts and hemorrhages. Since population-based studies indicate the prevalence of silent stroke is substantially higher than that of symptomatic stroke, estimates of stroke incidence based solely on symptomatic events may substantially underestimate the annual stroke burden.
The prevalence of silent infarcts for different age strata were abstracted from two US population-based MRI studies, the Atherosclerosis Risk in Communities Study and the Cardiovascular Health Study. Similarly, first silent cerebral hemorrhage incidence rates were derived from population-based MRI prevalence observations in the Austrian Stroke Prevention Study. Prevalence observations in these studies and death rates from the US Census were inputted to calculate age-specific first silent MRI infarct and hemorrhage incidence. Age- specific incidence rates were projected onto 1998 US population age cohorts to calculate the annual burden of first silent MRI ischemic stroke and first silent MRI cerebral hemorrhage.
Estimated age-specific annual incidence rates (per 100,000) of persons experiencing first silent MRI infarct ranged from 1,600 in the age 30-39 stratum to 16,400 at ages 75-79. Estimated incidence rates of first silent MRI cerebral hemorrhage ranged from 180 in the ages 30-39 to 6,900 at age >85. Overall, the projected annual incidence in 1998 of US individuals experiencing first silent MRI infarct was 9,040,000, and first silent MRI hemorrhage 1,940,000.
In 1998, more than 11 million persons experienced stroke in the US, in whom approximately 770,000 were symptomatic and 11 million were first-ever silent MRI infarcts or hemorrhages. These findings demonstrate the incidence of stroke is substantially higher than suggested by estimates based solely on clinically manifest events.
近期美国中风发病率的估计为每年76万至78万,然而这些估计并未反映无症状梗死和出血的发病率。由于基于人群的研究表明无症状中风的患病率远高于有症状中风,仅基于有症状事件的中风发病率估计可能会大幅低估年度中风负担。
从两项美国基于人群的MRI研究(社区动脉粥样硬化风险研究和心血管健康研究)中提取不同年龄层无症状梗死的患病率。同样,首次无症状脑出血发病率来自奥地利中风预防研究中基于人群的MRI患病率观察。将这些研究中的患病率观察结果和美国人口普查的死亡率输入,以计算特定年龄的首次无症状MRI梗死和出血发病率。将特定年龄发病率推算到1998年美国人口年龄队列上,以计算首次无症状MRI缺血性中风和首次无症状MRI脑出血的年度负担。
经历首次无症状MRI梗死的特定年龄年度发病率估计(每10万人)范围从30 - 39岁年龄层的1600到75 - 79岁的16400。首次无症状MRI脑出血的估计发病率范围从30 - 39岁的180到85岁以上的6900。总体而言,1998年美国经历首次无症状MRI梗死的预计年度发病率为904万,首次无症状MRI出血为194万。
1998年,美国有超过1100万人发生中风,其中约77万人有症状,1100万人是首次无症状MRI梗死或出血。这些发现表明中风发病率远高于仅基于临床表现事件的估计。